Guidance for hospital and clinical-based pharmacies as well as regulations related to commercial pharmacies.
President Donald Trump delivered his State of the Union address last Tuesday, in which he pledged to guarantee coverage for patients with pre-existing conditions, protect Medicare, and sign legislation to dramatically “lower prescription prices.”
Interested hospital-affiliated clinicians are invited to participate in one or more free, CME-credit-bearing webinars sponsored by Partners in Contraceptive Choice and Knowledge.
The Executive Office of Health & Human Services has released proposed regulations that would give MassHealth the authority to designate and exclude from MassHealth coverage high-cost drugs that are purchased under the 340B program.
The Executive Office of Health & Human Services has issued draft regulations governing pharmacy services delivered to MassHealth patients.
This week the state senate is expected to begin deliberations on pharmaceutical cost control legislation.
A new MassHealth policy that would require prior authorizations for more than 350 medical and diagnostic services is on hold for now.
The state’s Health Policy Commission (HPC) held its annual cost trends hearing last Tuesday and Wednesday.
This conference will look at effective current strategies for improved ROI across an enterprise.
The Medication Assisted Treatment (MAT) Commission has completed its mandated report to the legislature.
Governor Charlie Baker last Friday introduced the latest legislative proposal to reform the state’s healthcare system.
On September 24, Governor Charlie Baker declared a public health emergency due to severe lung disease associated with the use of e-cigarettes and vaping products.
Last week, a bipartisan Congressional letter, including signatures from Massachusetts Democrats James McGovern and Katherine Clark, asked the Interim FDA Commissioner when he expected the FDA to release its drug shortage report to Congress.
The Centers for Disease Control and Prevention (CDC) recently issued the 2019-20 influenza vaccine recommendations.
The federal government signaled last week that is moving to ban flavored e-cigarettes from the market.
Last Wednesday, the Public Health Council signed off on the final e-prescribing regulations, which go into effect on December 27, 2019.
The Executive Office of Health and Human Services (EOHHS) has issued proposed changes to the two regulations governing Health Safety Net (HSN) eligibility and payments.
The U.S. Department of Health and Human Services (HHS) announced last Wednesday that it would appeal a U.S. District Court judge’s ruling in July that struck down HHS’ plan to force pharmaceutical companies to disclose wholesale prices of their drugs
The Centers for Medicare and Medicaid Services (CMS) last week released the proposed payment rule for outpatient services as well as the physician fee schedule rule.
At its July 24 board meeting, the Health Policy Commission (HPC) released its final report (required by Section 130 of Chapter 47 of the Acts of 2017) on the use of third party specialty pharmacies for certain clinician-administered medications.
The US Senate Finance Committee advanced bi-partisan, compromise drug cost legislation on Thursday, despite opposition from a majority of the committee’s Republican members.


Click on the links below for easy access to important information related to state healthcare issues and advocacy.

Visit the Commonwealth of Massachusetts websites below to find information on legislative hearings and other meetings of interest to the healthcare community.

To guide your navigation of the legislative process and assist your advocacy efforts, please visit the following state websites: